Methylin ER Interactions
There are 198 drugs known to interact with Methylin ER (methylphenidate), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 20 are major, 167 are moderate, and 11 are minor.
- View all 198 medications that may interact with Methylin ER
- View Methylin ER alcohol/food interactions (4)
- View Methylin ER disease interactions (14)
Most frequently checked interactions
View interaction reports for Methylin ER (methylphenidate) and the medicines listed below.
- Abilify (aripiprazole)
- albuterol
- Ambien (zolpidem)
- amitriptyline
- aspirin
- Ativan (lorazepam)
- bupropion
- Celexa (citalopram)
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- fluoxetine
- gabapentin
- hydrochlorothiazide
- ibuprofen
- Klonopin (clonazepam)
- lamotrigine
- lisinopril
- lorazepam
- meloxicam
- metformin
- omeprazole
- Prozac (fluoxetine)
- sertraline
- simvastatin
- trazodone
- Vitamin D2 (ergocalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Methylin ER alcohol/food interactions
There are 4 alcohol/food interactions with Methylin ER (methylphenidate).
Methylin ER disease interactions
There are 14 disease interactions with Methylin ER (methylphenidate) which include:
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- substance abuse
- tics
- hypertension
- seizures disorders
- liver disease
- renal dysfunction
- seizure disorders
- hematologic toxicity
- GI narrowing
More about Methylin ER (methylphenidate)
- Methylin ER consumer information
- Compare alternatives
- Reviews (11)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.